본문 바로가기
KERD
논문KCI 등재

Understanding Schizophrenia as a Disorder of Consciousness: Biological Correlates and Translational Implications from Quantum Theory Perspectives

Ganesan Venkatasubramanian
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2015.04|Clinical Psychopharmacology and Neuroscience|제13권 제1호|pp. 36-47

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

SchizophreniaConsciousnessMicrotubulesQuantum theory

초록

From neurophenomenological perspectives, schizophrenia has been conceptualized as “a disorder with heterogeneous manifestations that can be integrally understood to involve fundamental perturbations in consciousness”. While these theoretical constructs based on consciousness facilitate understanding the ‘gestalt’ of schizophrenia, systematic research to unravel translational implications of these models is warranted. To address this, one needs to begin with exploration of plausible biological underpinnings of “perturbed consciousness” in schizophrenia. In this context, an attractive proposition to understand the biology of consciousness is “the orchestrated object reduction (Orch-OR) theory” which invokes quantum processes in the microtubules of neurons. The Orch-OR model is particularly important for understanding schizophrenia especially due to the shared ‘scaffold’ of microtubules. The initial sections of this review focus on the compelling evidence to support the view that “schizophrenia is a disorder of consciousness” through critical summary of the studies that have demonstrated self-abnormalities, aberrant time perception as well as dysfunctional intentional binding in this disorder. Subsequently, these findings are linked with ‘Orch-OR theory’ through the research evidence for aberrant neural oscillations as well as microtubule abnormalities observed in schizophrenia. Further sections emphasize the applicability and translational implications of Orch-OR theory in the context of schizophrenia and elucidate the relevance of quantum biology to understand the origins of this puzzling disorder as “fundamental disturbances in consciousness”.

Abstract

From neurophenomenological perspectives, schizophrenia has been conceptualized as “a disorder with heterogeneous manifestations that can be integrally understood to involve fundamental perturbations in consciousness”. While these theoretical constructs based on consciousness facilitate understanding the ‘gestalt’ of schizophrenia, systematic research to unravel translational implications of these models is warranted. To address this, one needs to begin with exploration of plausible biological underpinnings of “perturbed consciousness” in schizophrenia. In this context, an attractive proposition to understand the biology of consciousness is “the orchestrated object reduction (Orch-OR) theory” which invokes quantum processes in the microtubules of neurons. The Orch-OR model is particularly important for understanding schizophrenia especially due to the shared ‘scaffold’ of microtubules. The initial sections of this review focus on the compelling evidence to support the view that “schizophrenia is a disorder of consciousness” through critical summary of the studies that have demonstrated self-abnormalities, aberrant time perception as well as dysfunctional intentional binding in this disorder. Subsequently, these findings are linked with ‘Orch-OR theory’ through the research evidence for aberrant neural oscillations as well as microtubule abnormalities observed in schizophrenia. Further sections emphasize the applicability and translational implications of Orch-OR theory in the context of schizophrenia and elucidate the relevance of quantum biology to understand the origins of this puzzling disorder as “fundamental disturbances in consciousness”.

참고문헌 (121)

  1. van Os J., "Schizophrenia", Lancet, 374, pp.635~645 (2009)
  2. Northoff G., "Resting state activity and the"stream of consciousness"in schizophrenia-neurophenomenal hypotheses", Schizophr Bull, 41, pp.280~290 (2015)
  3. Howes OD., "Schizophrenia : an integrated sociodevelopmental-cognitive model", Lancet, 383, pp.1677~1687 (2014)
  4. Harrison PJ., "Schizophrenia genes, gene expression, and neuropathology : on the matter of their convergence", Mol Psychiatry, 10, pp.40~68 (2005)
  5. Insel TR., "Rethinking schizophrenia", Nature, 468, pp.187~193 (2010)
  6. Keshavan MS., "Schizophrenia, "Just the Facts"6. Moving ahead with the schizophrenia concept : from the elephant to the mouse", Schizophr Res, 127, pp.3~13 (2011)
  7. Ford JM., "Anticipating the future : automatic prediction failures in schizophrenia", Int J Psychophysiol, 83, pp.232~239 (2012)
  8. Lisman JE., "Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia", Trends Neurosci, 31, pp.234~242 (2008)
  9. Stephan KE., "Dysconnection in schizophrenia : from abnormal synaptic plasticity to failures of self-monitoring", Schizophr Bull, 35, pp.509~527 (2009)
  10. Debnath M., "Recent advances in psychoneuroimmunology relevant to schizophrenia therapeutics", Curr Opin Psychiatry, 26, pp.433~439 (2013)
  11. Venkatasubramanian G., "Schizophrenia is a disorder of aberrant neurodevelopment : A synthesis of evidence from clinical and structural, functional and neurochemical brain imaging studies", Indian J Psychiatry, 49, pp.244~249 (2007)
  12. Venkatasubramanian G., "The TRIPS(toll-like receptors in immuno-inflammatory pathogenesis)hypothesis : a novel postulate to understand schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 44, pp.301~311 (2013)
  13. Parnas J., "A disappearing heritage : the clinical core of schizophrenia", Schizophr Bull, 37, pp.1121~1130 (2011)
  14. Sass LA., "Schizophrenia, consciousness, and the self", Schizophr Bull, 29, pp.427~444 (2003)
  15. Taylor JG., "A neural model of the loss of self in schizophrenia", Schizophr Bull, 37, pp.1229~1247 (2011)
  16. Vogeley K., "Disturbances of time consciousness from a phenomenological and a neuroscientific perspective", Schizophr Bull, 33, pp.157~165 (2007)
  17. Henriksen MG., "Clinical manifestations of self-disorders and the Gestalt of schizophrenia", Schizophr Bull, 38, pp.657~660 (2012)
  18. Parnas J., "The core Gestalt of schizophrenia", World Psychiatry, 11, pp.67~69 (2012)
  19. Maj M., "The self and schizophrenia : some open issues", World Psychiatry, 11, pp.65~66 (2012)
  20. Hameroff S., "Consciousness in the universe : a review of the ‘Orch OR’ theory", Phys Life Rev, 11, pp.39~78 (2014)
  21. Woolf NJ., "Neuropsychiatric illness : a case for impaired neuroplasticity and possible quantum processing derailment in microtubules", NeuoQuantology, 8, pp.13~28 (2010)
  22. Werneke U., "Psychiatry and reality. Perception of matter or matter of perception?", NeuoQuantology, 9, pp.190~201 (2011)
  23. Lambert N., "Quantum biology", Nature Physics, 9, pp.10~18 (2013)
  24. Fleming GR., "Quantum effects in biology", Procedia Chem, 3, pp.38~57 (2011)
  25. Sahu S., "Atomic water channel controlling remarkable properties of a single brain microtubule : correlating single protein to its supramolecular assembly", Biosens Bioelectron, 47, pp.141~148 (2013)
  26. Craddock TJ., "Cytoskeletal signaling : is memory encoded in microtubule lattices by CaMKII phosphorylation?", PLoS Comput Biol, 8, pp.e1002421~ (2012)
  27. Ghosh S., "Evidence of massive global synchronization and the consciousness: comment on "Consciousness in the universe: a review of the 'Orch OR' theory" by Hameroff and Penrose", Phys Life Rev, 11, pp.83~84 (2014)
  28. Miller G., "What is the biological basis of consciousness?", Science, 309, pp.79~ (2005)
  29. Chopra D., "Reality and consciousness: a view from the East: comment on "Consciousness in the universe: a review of the 'Orch OR' theory" by Stuart Hameroff and Roger Penrose", Phys Life Rev, 11, pp.81~82 (2014)
  30. Tuszynski JA., "The emerging physics of consciousness", pp.1~26 (2006), Springer-Verlag
  31. Northoff G., "Brain and self-a neurophilosophical account", Child Adolesc Psychiatry Ment Health, 7, pp.28~ (2013)
  32. Nelson B., "Disturbance of minimal self(ipseity)in schizophrenia : clarification and current status", Schizophr Bull, 40, pp.479~482 (2014)
  33. Hur JW., "The crisis of minimal self-awareness in schizophrenia : a meta-analytic review", Schizophr Res, 152, pp.58~64 (2014)
  34. Sass LA., "Self-disturbance and schizophrenia : structure, specificity, pathogenesis(current issues, new directions)", Schizophr Res, 152, pp.5~11 (2014)
  35. Varela FJ., "Naturalizing phenomenology. Issues in contemporary phenomenology and cognitive science", pp.266~314 (1999), Stanford University Press
  36. Bonnot O., "Are impairments of time perception in schizophrenia a neglected phenomenon?", J Physiol Paris, 105, pp.164~169 (2011)
  37. Gómez J., "Time perception networks and cognition in schizophrenia : A review and a proposal", Psychiatry Res, 220, pp.737~744 (2014)
  38. Buhusi CV., "What makes us tick? Functional and neural mechanisms of interval timing", Nat Rev Neurosci, 6, pp.755~765 (2005)
  39. Waters F., "Time discrimination deficits in schizophrenia patients with first-rank(passivity)symptoms", Psychiatry Res, 167, pp.12~20 (2009)
  40. Papageorgiou C., "Temporal processing dysfunction in schizophrenia as measured by time interval discrimination and tempo reproduction tasks", Prog Neuropsychopharmacol Biol Psychiatry, 40, pp.173~179 (2013)
  41. Coull JT., "Neuroanatomical and neurochemical substrates of timing", Neuropsychopharmacology, 36, pp.3~25 (2011)
  42. Coull JT., "Ketamine perturbs perception of the flow of time in healthy volunteers", Psychopharmacology(Berl), 218, pp.543~556 (2011)
  43. Corlett PR., "Glutamatergic model psychoses : prediction error, learning, and inference", Neuropsychopharmacology, 36, pp.294~315 (2011)
  44. Haggard P., "Voluntary action and conscious awareness", Nat Neurosci, 5, pp.382~385 (2002)
  45. Moore JW., "Intentional binding and the sense of agency : a review", Conscious Cogn, 21, pp.546~561 (2012)
  46. Hughes G., "Mechanisms of intentional binding and sensory attenuation : the role of temporal prediction, temporal control, identity prediction, and motor prediction", Psychol Bull, 139, pp.133~151 (2013)
  47. Haggard P., "Awareness of action in schizophrenia", Neuroreport, 14, pp.1081~1085 (2003)
  48. Hauser M., "Sense of agency is altered in patients with a putative psychotic prodrome", Schizophr Res, 126, pp.20~27 (2011)
  49. Franck N., "Altered subjective time of events in schizophrenia", J Nerv Ment Dis, 193, pp.350~353 (2005)
  50. Voss M., "Altered awareness of action in schizophrenia : a specific deficit in predicting action consequences", Brain, 133, pp.3104~3112 (2010)
  51. Moore J., "Awareness of action : Inference and prediction", Conscious Cogn, 17, pp.136~144 (2008)
  52. Synofzik M., "Misattributions of agency in schizophrenia are based on imprecise predictions about the sensory consequences of one's actions", Brain, 133, pp.262~271 (2010)
  53. Frith C., "Explaining delusions of control : the comparator model 20 years on", Conscious Cogn, 21, pp.52~54 (2012)
  54. Moore JW., "Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia", Cogn Neuropsychiatry, 16, pp.364~381 (2011)
  55. Moore JW., "Dopaminergic medication boosts action-effect binding in Parkinson's disease", Neuropsychologia, 48, pp.1125~1132 (2010)
  56. Allman MJ., "Pathophysiological distortions in time perception and timed performance", Brain, 135, pp.656~677 (2012)
  57. Matell MS., "Cortico-striatal circuits and interval timing : coincidence detection of oscillatory processes", Brain Res Cogn Brain Res, 21, pp.139~170 (2004)
  58. Andreasen NC., ""Cognitive dysmetria"as an integrative theory of schizophrenia : a dysfunction in cortical-subcortical-cerebellar circuitry?", Schizophr Bull, 24, pp.203~218 (1998)
  59. Venkatasubramanian G., "Striato-cerebellar abnormalities in never-treated schizophrenia : evidence for neurodevelopmental etiopathogenesis", German J Psychiatry, 6, pp.1~7 (2003)
  60. Uhlhaas PJ., "Abnormal neural oscillations and synchrony in schizophrenia", Nat Rev Neurosci, 11, pp.100~113 (2010)
  61. Uhlhaas PJ., "The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia", Schizophr Bull, 34, pp.927~943 (2008)
  62. Kaiser J., "Prefrontal gamma-band activity distinguishes between sound durations", Brain Res, 1139, pp.153~162 (2007)
  63. Wilson TW., "Estimating the passage of minutes : deviant oscillatory frontal activity in medicated and unmedicated ADHD", Neuropsychology, 27, pp.654~665 (2013)
  64. Spellman TJ., "Synchrony in schizophrenia: a window into circuit-level pathophysiology", Curr Opin Neurobiol, 30C, pp.17~23 (2014)
  65. Uhlhaas PJ., "High-frequency oscillations and the neurobiology of schizophrenia", Dialogues Clin Neurosci, 15, pp.301~313 (2013)
  66. Craddock TJ., "Keeping time : could quantum beating in microtubules be the basis for the neural synchrony related to consciousness?", J Integr Neurosci, 13, pp.293~311 (2014)
  67. Faber J., "Information processing in brain microtubules", Biosystems, 83, pp.1~9 (2006)
  68. Avila J., "Role of tau protein in both physiological and pathological conditions", Physiol Rev, 84, pp.361~384 (2004)
  69. Cantero JL., "Role of tau protein on neocortical and hippocampal oscillatory patterns", Hippocampus, 21, pp.827~834 (2011)
  70. Gonzalez-Burgos G., "NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia", Schizophr Bull, 38, pp.950~957 (2012)
  71. Boley AM., "A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia", Schizophr Res, 157, pp.238~243 (2014)
  72. Jiang Z., "Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia", Front Behav Neurosci, 7, pp.116~ (2013)
  73. Conde C., "Microtubule assembly, organization and dynamics in axons and dendrites", Nat Rev Neurosci, 10, pp.319~332 (2009)
  74. Arnold SE., "Abnormal expression of two microtubule-associated proteins(MAP2 and MAP5)in specific subfields of the hippocampal formation in schizophrenia", Proc Natl Acad Sci U S A, 88, pp.10850~10854 (1991)
  75. Benitez-King G., "The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia", Curr Drug Targets CNS Neurol Disord, 3, pp.515~533 (2004)
  76. Balu DT., "Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia", Neurosci Biobehav Rev, 35, pp.848~870 (2011)
  77. Selemon LD., "The reduced neuropil hypothesis : a circuit based model of schizophrenia", Biol Psychiatry, 45, pp.17~25 (1999)
  78. Garey L., "When cortical development goes wrong : schizophrenia as a neurodevelopmental disease of microcircuits", J Anat, 217, pp.324~333 (2010)
  79. Merriam EB., "Dynamic microtubules promote synaptic NMDA receptor-dependent spine enlargement", PLoS One, 6, pp.e27688~ (2011)
  80. Costas J., "Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs", Ann Hum Genet, 77, pp.504~512 (2013)
  81. Volle J., "Reduced expression of STOP", MAP6 in mice leads to cognitive deficits, 2013, pp.39, 969~978
  82. Deutsch SI., "Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.1369~1380 (2006)
  83. Andrieux A., "Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia", Biol Psychiatry, 60, pp.1224~1230 (2006)
  84. Andrieux A., "The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders", Genes Dev, 16, pp.2350~2364 (2002)
  85. Lepage M., "Neurocognition : clinical and functional outcomes in schizophrenia", Can J Psychiatry, 59, pp.5~12 (2014)
  86. Brandon NJ., "Linking neurodevelopmental and synaptic theories of mental illness through DISC1", Nat Rev Neurosci, 12, pp.707~722 (2011)
  87. Thyberg J., "In vitro effects of chlorpromazine on microtubules and the Golgi complex in embryonic chick spinal ganglion cells : an electron microscopic study", Brain Res, 137, pp.323~332 (1977)
  88. Harrison PJ., "The neuropathological effects of antipsychotic drugs", Schizophr Res, 40, pp.87~99 (1999)
  89. Rizig MA., "A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia", J Psychopharmacol, 26, pp.1218~1230 (2012)
  90. Subburaju S., "Induction of the GABA cell phenotype : an in vitro model for studying neurodevelopmental disorders", PLoS One, 7, pp.e33352~ (2012)
  91. Kalmady SV., "Relationship between brainderived neurotrophic factor and schneiderian first rank symptoms in antipsychotic-naïve schizophrenia", Front Psychiatry, 4, pp.64~ (2013)
  92. Fernandes BS, "Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications", Mol Psychiatry (2014)[DOI]
  93. Green MJ., "Brain-derived neurotrophic factor levels in schizophrenia : a systematic review with meta-analysis", Mol Psychiatry, 16, pp.960~972 (2011)
  94. Bose A., "Cognitive mapping deficits in schizophrenia : a critical overview", Indian J Psychol Med, 36, pp.9~26 (2014)
  95. Tamminga CA., "The hippocampal formation in schizophrenia", Am J Psychiatry, 167, pp.1178~1193 (2010)
  96. Panja D., "BDNF mechanisms in late LTP formation: a synthesis and breakdown", Neuropharmacology, 76(Pt C), pp.664~676 (2014)
  97. Eisenberg DP., "Hippocampal dysfunction in schizophrenia : association with brain-derived neurotrophic factor genotype", Mol Psychiatry, 18, pp.631~ (2013)
  98. Brun P., "Dopaminergic transmission in STOP null mice", J Neurochem, 94, pp.63~73 (2005)
  99. Buttrick GJ., "PI3-K and GSK-3 : Akt-ing together with microtubules", Cell Cycle, 7, pp.2621~2625 (2008)
  100. Carter CJ., "Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens : cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii", Schizophr Bull, 35, pp.1163~1182 (2009)
  101. Ganesan Venkatasubramanian, "Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis", Clinical Psychopharmacology and Neuroscience, 12(1), pp.8~18 (2014), 대한정신약물학회
  102. Thalbourne MA., "Relation between transliminality and openness to experience", Psychol Rep, 86, pp.909~910 (2000)
  103. Thalbourne MA., "Measures of the sheep-goat variable, transliminality, and their correlates", Psychol Rep, 88, pp.339~350 (2001)
  104. Lange R., "The revised transliminality scale : reliability and validity data from a Rasch top-down purification procedure", Conscious Cogn, 9, pp.591~617 (2000)
  105. Fleck JI., "The transliminal brain at rest : baseline EEG, unusual experiences, and access to unconscious mental activity", Cortex, 44, pp.1353~1363 (2008)
  106. Crow TJ., "Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease", Arch Gen Psychiatry, 46, pp.1145~1150 (1989)
  107. Crow TJ., "Is schizophrenia the price that Homo sapiens pays for language?", Schizophr Res, 28, pp.127~141 (1997)
  108. Persinger MA., "Protracted parahippocampal activity associated with Sean Harribance", Int J Yoga, 5, pp.140~145 (2012)
  109. Venkatasubramanian G., "Investigating paranormal phenomena : Functional brain imaging of telepathy", Int J Yoga, 1, pp.66~71 (2008)
  110. Leonhard D., "Creative, paranormal, and delusional thought : a consequence of right hemisphere semantic activation?", Neuropsychiatry Neuropsychol Behav Neurol, 11, pp.177~183 (1998)
  111. Venkatasubramanian G., "Reformulating schizophrenia : the importance of evolutionary theories", Med Hypotheses, 72, pp.229~230 (2009)
  112. Mitchell RL., "Right hemisphere language functions and schizophrenia : the forgotten hemisphere?", Brain, 128, pp.963~978 (2005)
  113. Zhang Y., "Exploratory quantum resonance spectrometer as a discriminator for psychiatric affective disorders", J Nerv Ment Dis, 202, pp.287~291 (2014)
  114. Pei Q., "Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconvulsive shock", Neuroreport, 9, pp.391~394 (1998)
  115. Anthony A. Grace, "Hippocampal Dysregulation of Dopamine System Activity as a Pathophysiological Basis for Psychosis in Schizophrenia", Clinical Psychopharmacology and Neuroscience, 8(1), pp.1~9 (2010), 대한정신약물학회
  116. Gozes I., "Microtubules, schizophrenia and cognitive behavior : preclinical development of davunetide(NAP)as a peptide-drug candidate", Peptides, 32, pp.428~431 (2011)
  117. Javitt DC., "Effect of the neuroprotective peptide davunetide(AL-108)on cognition and functional capacity in schizophrenia", Schizophr Res, 136, pp.25~31 (2012)
  118. Jarskog LF., "Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia", Neuropsychopharmacology, 38, pp.1245~1252 (2013)
  119. Hameroff S., "Transcranial ultrasound(TUS)effects on mental states : a pilot study", Brain Stimul, 6, pp.409~415 (2013)
  120. Mueller J., "Transcranial focused ultrasound modulates intrinsic and evoked EEG dynamics", Brain Stimul, 7, pp.900~908 (2014)
  121. Legon W., "Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans", Nat Neurosci, 17, pp.322~329 (2014)

관련 논문AI추천

Gamma Oscillation in Schizophrenia권준수, 신용욱, Brian F. O’Donnell, Soyoung Youn대한신경정신의학회 · PSYCHIATRY INVESTIGATION2011 · 제8권 제4호Schizophrenia and Corollary Discharge: A Neuroscientific Overview and Translational ImplicationsAnushree Bose, Ganesan Venkatasubramanian, Rujuta Parlikar대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2019 · 제17권 제2호Electric Conduction Effects in the Neuronal Cytoskeleton Hold the Key to Our Understanding of the Biophysics of ConsciousnessJack A. Tuszyński인지과학연구소 · Journal of Cognitive Science2018 · 제19권 제2호Nonlinear Analysis of Electroencephalogram in Schizophrenia Patients with Persistent Auditory Hallucination이승환, 채정호, Jung- Suk Choo, Wu-Young Im대한신경정신의학회 · PSYCHIATRY INVESTIGATION2008 · 제5권 제2호지향성의 시간적 구조와 조현병의 정신병리김희철대한신경정신의학회 · 신경정신의학2025 · 제64권 제4호Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation StrategiesAdarsh Tripathi, Rashmi Shukla, Sujita Kumar Kar대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2018 · 제16권 제1호

이 간행물의 다른 논문 (13건)

Tobacco Use in Bipolar DisorderMIchael Berk, Olivia M. Dean, Seetal Dodd, Lesley Berk, Daniel Thomson, Marta Rapado-Castro, Shae E. Quirk, Pernille K. Ellegaardpp. 1-11N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic ReviewMichael Berk, Olivia Dean, Jerome Sarris, David Camfield, Georgina Oliver, Scott Blair-West, Chee Ngpp. 12-24Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an UpdateAther Muneerpp. 25-35Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar SampleJoseph Zohar, Leonardo Zaninotto, Raffaella Calati, Giovanni Camardese, Stuart Montgomery, Siegfried Kasper, Diana De Ronchi, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Luigi Janiripp. 48-52Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine Transporter Genetic Variation on Antidepressant Efficacy in Major Depression: A Pilot StudyChad A. Bousman, Chee Hong Ng, Keith Byron, Ajeet Bhagat Singh, MIchael Berkpp. 53-61
원문 보기